ENTRADA THERAPEUTICS, INC. (TRDA) Operating cash flow 2020–2025
ENTRADA THERAPEUTICS, INC. (TRDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$128.5MFY2025 · since FY2020: -$25.6M → -$128.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.5M | -209.2% |
| FY2024 | -$41.6M | -129.7% |
| FY2023 | $139.8M | +249.1% |
| FY2022 | -$93.8M | -84.4% |
| FY2021 | -$50.9M | -98.9% |
| FY2020 | -$25.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TRDA financial trends
TRDA RevenueTRDA Net incomeTRDA Net marginTRDA Gross profitTRDA Gross marginTRDA Operating incomeTRDA Operating marginTRDA Free cash flowTRDA Capital expendituresTRDA Return on equityTRDA Stock buybacksTRDA Dividends paidTRDA Total assetsTRDA Total liabilitiesTRDA Shareholders’ equityTRDA overview →